Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study

BACKGROUND: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare interstitial lung disease. COVID-19 is associated with worse prognosis in previous lung diseases patients. But the prognosis of aPAP patients after infection with COVID-19 is unclear. In December 2022, China experienced a large-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Chuanxin, Zhou, Wangji, Zhang, Miaoyan, Cheng, Chongsheng, Xu, Wenshuai, Dai, Jinrong, Meng, Shuzhen, Chen, Keqi, Zhao, Yang, Liu, Song, Wang, Shao-Ting, Yang, Yanli, Xu, Kai-Feng, Tian, Xinlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638736/
https://www.ncbi.nlm.nih.gov/pubmed/37951939
http://dx.doi.org/10.1186/s13023-023-02950-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638736/
https://www.ncbi.nlm.nih.gov/pubmed/37951939
http://dx.doi.org/10.1186/s13023-023-02950-9

Ejemplares similares